Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Individual Dosage Selection of Irinotecan(CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2013 by The Affiliated Hospital of the Chinese Academy of Military Medical Sciences.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
ClinicalTrials.gov Identifier:
NCT01523431
First received: January 19, 2012
Last updated: December 26, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2014
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)